These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5285342)
21. Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity. Walker SM; Lucas ZJ J Immunol; 1972 Dec; 109(6):1233-44. PubMed ID: 5086236 [No Abstract] [Full Text] [Related]
22. Functional heterogeneity of murine lymphoid cells. II. Acquisition of mitogen responsiveness and of theta antigen during the ontogeny of thymocytes and "T" lymphocytes. Stobo JD; Paul WE Cell Immunol; 1972 Aug; 4(4):367-80. PubMed ID: 4115122 [No Abstract] [Full Text] [Related]
24. Cytotoxic effects of activated lymphocytes and their supernatants. Holm G; Stejskal V; Perlmann P Clin Exp Immunol; 1973 Jun; 14(2):169-79. PubMed ID: 4717912 [TBL] [Abstract][Full Text] [Related]
25. The immune reactivity of heterologous antisera against a solubilized human lymphoid membrane component. Einstein AB; Mann DL; Gordon HG; Fahey JL Tissue Antigens; 1971; 1(5):209-18. PubMed ID: 5172713 [No Abstract] [Full Text] [Related]
26. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations. Gelfand EW; Resch K; Prester M Eur J Immunol; 1972 Oct; 2(5):419-24. PubMed ID: 5084393 [No Abstract] [Full Text] [Related]
27. Dynamics of interaction between allogeneic immune and non-immune lymphocytes and target cells in tissue culture. Chernyakhovskaya IJ; Kadaghidze ZG; Slavina HG; Dook IL; Svet-Moldavsky GJ Folia Biol (Praha); 1970; 16(5):336-46. PubMed ID: 5529653 [No Abstract] [Full Text] [Related]
29. Allograft immunity in vitro. VI. Autonomy of T lymphocytes in target cell destruction. Andersson LC; Nordling S; Häyry P Scand J Immunol; 1973; 2(2):107-13. PubMed ID: 4269569 [No Abstract] [Full Text] [Related]
30. A sensitive microassay system for lymphocyte-mediated cytotoxicity induced by PHA and PPD. Amino N; Degroot LJ J Immunol; 1973 Aug; 111(2):464-71. PubMed ID: 4717990 [No Abstract] [Full Text] [Related]
31. Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity. Dickmeiss E; Nielsen LS Scand J Immunol; 1974; 3(2):199-207. PubMed ID: 4822686 [No Abstract] [Full Text] [Related]
32. The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. MacLennan IC; Loewi G; Harding B Immunology; 1970 Mar; 18(3):397-404. PubMed ID: 4191812 [TBL] [Abstract][Full Text] [Related]
33. A quantitative assay of PHA mediated cytotoxicity of isogeneic, allogeneic, and semi-isogeneic mouse and rat lymphocytes. Malchow H; Zeiss IM; Ax W; Szenberg A; Fischer H Int Arch Allergy Appl Immunol; 1969; 35(5):495-503. PubMed ID: 5781776 [No Abstract] [Full Text] [Related]
34. In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Hiserodt JC; Prieur AM; Granger GA Cell Immunol; 1976 Jun; 24(2):277-88. PubMed ID: 1084788 [No Abstract] [Full Text] [Related]
35. Immune lysis of normal and AET-treated lymphocytes: a study of transmission and scanning electron microscopy. Lambertenghi-Deliliers G; Ferrone S; Ranzi T; Sirchia G Blood; 1971 Dec; 38(6):759-68. PubMed ID: 5126164 [No Abstract] [Full Text] [Related]
36. Characteristics of a cytotoxin ("lymphotoxin") produced by stimulation of human lymphoid tissue. Peter JB; Stratton JA; Stempel KE; Yu D; Cardin C J Immunol; 1973 Sep; 111(3):770-82. PubMed ID: 4741296 [No Abstract] [Full Text] [Related]
37. Selective cytotoxicity of anti-kappa serum for B lymphocytes. Miller JF; Sprent J; Basten A; Warner NL Nat New Biol; 1972 May; 237(70):18-20. PubMed ID: 4113235 [No Abstract] [Full Text] [Related]
38. Effect of neuraminidase on serological properties of murine lymphoid cells. Schlesinger M; Amos BD Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346 [No Abstract] [Full Text] [Related]
39. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase. Reisner EG; Amos DB Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957 [No Abstract] [Full Text] [Related]
40. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS). Sherwood G; Blaese RM Clin Exp Immunol; 1973 Apr; 13(4):515-20. PubMed ID: 4736825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]